The Research on Lignans
and Prostate Health
Prostate cancer is the second most commonly diagnosed form of cancer and the No. 2 cause of cancer death among U.S. men, according
to the American Cancer Society. It is estimated that 200,000 new cases of prostate cancer will be diagnosed and 32,000
men will die of it in 2002. By age 50, 15 to 30 percent of men already have some cancer cells present within the prostate
gland. Keeping DHT levels in check is considered to be an important step in preventing those cancer cells from dividing and
spreading en masse throughout the prostate gland and metastasizing to other parts of the body. Thus, the ingestion of lignans
on a daily basis provides important bioactive agents that indirectly slow the rate of prostate cell division, reducing the
chances of prostate enlargement (benign prostatic hyperplasia) and hindering the promotion of cancer development. Phytoestrogens,
such as lignans, also bind to receptors on the prostate gland helping to block the influence of other hormones, which may
stimulate rapid prostate cell division. Prostate cancer is the most common cancer in men and prostate enlargement problems
will affect 80 percent of men if they live to old age.
Although there are highly invasive treatments for prostate cancer, more and more studies are being conducted on natural treatments
that may prove to be effective with little or no side effects. Studies also indicate that lignan supplements
may also add to the benefit of conventional treatments. The below information is on some of the more prevalent studies
conducted on lignans and prostate cancer.
Also, see the below links on prostate cancer and lignans in the news.